Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aytu Bioscience Inc (AYTU)

Aytu Bioscience Inc (AYTU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,604
  • Shares Outstanding, K 125,837
  • Annual Sales, $ 27,630 K
  • Annual Income, $ -13,620 K
  • 60-Month Beta -0.29
  • Price/Sales 4.60
  • Price/Cash Flow N/A
  • Price/Book 1.28
Trade AYTU with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +81.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9700 +5.15%
on 10/26/20
1.4000 -27.14%
on 10/06/20
-0.1600 (-13.56%)
since 09/25/20
3-Month
0.9031 +12.94%
on 09/04/20
1.4900 -31.54%
on 07/31/20
-0.3600 (-26.09%)
since 07/24/20
52-Week
0.3352 +204.30%
on 03/09/20
2.9900 -65.89%
on 03/10/20
-0.1000 (-8.93%)
since 10/25/19

Most Recent Stories

More News
More Stringent Testing is Planned in a Bid to Return to Normalcy

, /PRNewswire/ -- As the economy slowly resumes its activity, it is more important than ever to provide a vast and effective testing network across the country. With testing, various regulatory bodies...

TOMDF : 0.0521 (-10.17%)
CODX : 14.04 (+12.68%)
AYTU : 1.0200 (+3.01%)
CEMI : 5.00 (+1.42%)
OPK : 4.31 (+0.23%)
Innovative Approaches Lead to Novel Methods of Treatment for Viral Infections

, /PRNewswire/ -- Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi and parasites, and can be transmitted by direct or indirect contact. Globally, infectious...

SBFMD : 0.0016 (-5.88%)
SBFM : 0.0184 (-3.66%)
RLFTF : 0.5790 (+7.22%)
VBIV : 2.46 (-3.53%)
IBIO : 1.8500 (-4.15%)
AYTU : 1.0200 (+3.01%)
Aytu BioScience Announces Fiscal Q4 2020 Net Revenue of $14.9 Million, an Increase of 82% Sequentially, and 766% Year-Over-Year

INNV : 1.2300 (+6.03%)
AYTU : 1.0200 (+3.01%)
Aytu BioScience to Report Fourth Quarter and Full Year Fiscal 2020 Results and Provide Business Update on Tuesday, October 6, 2020

Live Conference Call and Webcast at 4:30 PM ET

AYTU : 1.0200 (+3.01%)
Aytu BioScience to Reschedule Fourth Quarter and FY 2020 Conference Call

ENGLEWOOD, CO / ACCESSWIRE / September 23, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant...

INNV : 1.2300 (+6.03%)
AYTU : 1.0200 (+3.01%)
Thinking about buying stock in Northern Dynasty Minerals, Checkpoint Therapeutics, Rigel Pharmaceuticals, Vaxart, or Aytu Bioscience?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAK, CKPT, RIGL, VXRT, and AYTU.

AYTU : 1.0200 (+3.01%)
CKPT : 2.36 (-3.28%)
NAK : 1.0100 (-1.94%)
RIGL : 2.44 (-0.81%)
Aytu BioScience to Report Fourth Quarter FY 2020 Results and Business Update on Thursday, September 24, 2020

Live Conference Call and Webcast at 4:30 ET

AYTU : 1.0200 (+3.01%)
Unprecedented Global Events Lead Diagnostic Providers to Innovative Breakthroughs

, /PRNewswire/ -- As the pandemic continues to spread throughout the U.S., the need for testing is on the rise as well. Nevertheless, many states and regions are experiencing a shortage of tests, which...

TOMDF : 0.0521 (-10.17%)
AYTU : 1.0200 (+3.01%)
DVAX : 3.93 (-5.53%)
CODX : 14.04 (+12.68%)
PTE : 1.1300 (+13.06%)
OPK : 4.31 (+0.23%)
Thinking about buying stock in Vaxart Inc, Aytu Bioscience, Lakeland Industries, United Airlines, or Nio Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VXRT, AYTU, LAKE, UAL, and NIO.

AYTU : 1.0200 (+3.01%)
LAKE : 24.49 (-0.20%)
NIO : 26.01 (-4.23%)
Aytu BioScience Announces Global Agreement to Distribute Pinnacle IVD Corporation's 15-Minute COVID-19 Antigen Test

Pinnacle Plans to Scale U.S. Manufacturing Capacity to 25 Million Tests Per Month

AYTU : 1.0200 (+3.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual...

See More

Key Turning Points

2nd Resistance Point 1.0533
1st Resistance Point 1.0367
Last Price 1.0200
1st Support Level 0.9867
2nd Support Level 0.9533

See More

52-Week High 2.9900
Fibonacci 61.8% 1.9759
Fibonacci 50% 1.6626
Fibonacci 38.2% 1.3493
Last Price 1.0200
52-Week Low 0.3352

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar